Paul L. Nguyen, MD, on Predicting Metastasis and Mortality
2017 Genitourinary Cancers SymposiumPaul L. Nguyen, MD, of the Dana-Farber Cancer Institute, discuses an evaluation of the Decipher prostate cancer classifier to predict metastasis and disease-specific mortality from genomic analysis of diagnostic needle biopsy specimens. (Abstract 4)
Related Videos
Paul L. Nguyen, MD, on Prostate Cancer: Active Surveillance
Paul L. Nguyen, MD, of the Dana-Farber Cancer Institute, summarizes a session he co-chaired, which included discussion of Canadian vs U.S. guidelines; ProtecT; genomic and hereditary ...
Roland Seiler, MD, on Bladder Cancer: Subtypes and Treatment Response (German Language Version)
Roland Seiler, MD, of the University of British Columbia, discusses in German a way to identify molecular subtypes of muscle-invasive bladder cancer, the varying responses to cisplati...
Joshua Armenia, PhD, on Prostate Cancer: Recent Discoveries
Joshua Armenia, PhD, of Memorial Sloan Kettering Cancer Center, discusses new information that is changing the understanding of prostate cancer, including the identification of a new ...
Sumanta K. Pal, MD, on Advanced Renal Cancer: Treatment Challenges
Sumanta K. Pal, MD, of the City of Hope, summarizes a session he co-chaired on the opportunities and challenges in systemic therapy for advanced renal cancer, including imaging as a b...
Emma Hall, PhD, on Bladder Cancer: Results From the BC2001 Trial
Emma Hall, PhD, of the Institute of Cancer Research, London, discusses long-term outcomes with chemoradiotherapy vs radiotherapy alone, and standard vs reduced high-dose volume radiot...
